Abstract:Nanofabrication can help us to emulate natural intelligence. Forward-engineering brain gained enormous momentum but still falls short in human neurodegenerative disease modeling. Here, organ-on-chip (OoC) implementation of tissue culture concepts in microfluidic formats already progressed with the identification of our knowledge gap in toxicology and drug metabolism studies. We believe that the self-organization of stem cells and chip technology is a key to advance such complex in vitro tissue models, including models of the human nervous system as envisaged in this review. However, current cultured networks of neurons show limited resemblance with the biological functions in the real nervous system or brain tissues. To take full advantage of scaling in the engineering domain of electron-, ion-, and photon beam technology and nanofabrication methods, more research is needed to meet the requirements of this specific field of chip technology applications. So far, surface topographies, microfluidics, and sensor and actuator integration concepts have all contributed to the patterning and control of neural network formation processes in vitro. However, when probing the state of the art for this type of miniaturized three-dimensional tissue models in PubMed, it was realized that there is very little systematic cross-disciplinary research with biomaterials originally formed for tissue engineering purposes translated to on-chip solutions for in vitro modeling. Therefore, this review contributes to the formulation of a sound design concept based on the understanding of the existing knowledge and the technical challenges toward finding better treatments and potential cures for devastating neurodegenerative diseases, like Parkinson's disease. Subsequently, an integration strategy based on a modular approach is proposed for nervous system-on-chip (NoC) models that can yield efficient and informative optical and electronic NoC readouts in validating and optimizing these conceptual choices in the innovative process of a fast growing and exciting new OoC industry.

Neuromorphic computing for modeling neurological and psychiatric disorders: implications for drug development

Neuromorphic applications in medicine

Artificial Intelligence in The Management of Neurodegenerative Disorders

Neuromorphic Neuromodulation: Towards the next generation of on-device AI-revolution in electroceuticals

Exploring the applications of formulation-based drug development strategies in neurological disorders using artificial intelligence and machine learning approaches

Studying synaptic plasticity in the human brain and opportunities for drug discovery

A Survey of Neuromorphic Computing and Neural Networks in Hardware

Unraveling brain diseases: The promise of brain-on-a-chip models

Beyond animal models: revolutionizing neurodegenerative disease modeling using 3D in vitro organoids, microfluidic chips, and bioprinting

Whole brain modelling for simulating pharmacological interventions on patients with disorders of consciousness

Nanofabricating neural networks: Strategies, advances, and challenges

Emerging Memory-Based Chip Development for Neuromorphic Computing: Status, Challenges, and Perspectives

Towards Reverse-Engineering the Brain: Brain-Derived Neuromorphic Computing Approach with Photonic, Electronic, and Ionic Dynamicity in 3D integrated circuits

Microfluidic Brain-on-a-Chip: Perspectives for Mimicking Neural System Disorders

Modeling the neuroimmune system in Alzheimer's and Parkinson's diseases

Artificial intelligence and machine learning‐aided drug discovery in central nervous system diseases: State‐of‐the‐arts and future directions

Induced Pluripotent Stem Cells in Drug Discovery and Neurodegenerative Disease Modelling

Physics for Neuromorphic Computing

Computing of Neuromorphic Materials: An Emerging Approach for Bioengineering Solutions

Exploring Neuromorphic Computing Based on Spiking Neural Networks: Algorithms to Hardware

Optogenetic and chemogenetic approaches for modeling neurological disorders in vivo